Can I Get Chemotherapy in China While Keeping My NHS Oncologist?

Yes — Dual-Track Cancer Care Is Possible

The short answer is yes. UK patients can receive chemotherapy at a Chinese Grade 3A hospital while keeping their NHS oncologist as the lead clinician for their overall care. This is increasingly referred to as dual-track care, and it is becoming a recognised option for patients who face long NHS waits, who want access to therapies not yet approved in the UK, or who simply want to combine treatment with a meaningful recovery experience.

You do not need to deregister from your NHS oncology team, transfer your care, or seek NHS permission to pursue treatment abroad. Your NHS oncologist remains responsible for your overall treatment plan, follow-up imaging, surveillance, and long-term survivorship care. The Chinese oncology team provides the in-country chemotherapy, supportive care, and toxicity management, and communicates with your NHS team via shared clinical documentation.

How Dual-Track Cancer Care Works

Effective dual-track care requires three things: clear communication between the two teams, well-organised handover of clinical records, and an explicit plan for what happens before, during, and after each treatment cycle. Discovery China coordinates all three.

Step 1: Pre-Treatment Coordination

Before you travel, the Chinese oncology team needs a complete picture of your diagnosis and treatment history. This typically includes:

• Histology / pathology report — the definitive diagnosis, including tumour type, grade, and receptor status
• Staging imaging — CT, MRI, or PET-CT scans, ideally within 8 weeks of travel
• Molecular / genetic testing — KRAS, EGFR, BRCA, PD-L1, HER2, ALK, BRAF, MSI status — whatever is relevant to your cancer type
• Prior treatment summary — what you have had, response assessment, and any toxicity
• Current medications and allergies
• Your NHS oncologist's direct contact details — for clinician-to-clinician consultation

Once received, the Chinese team reviews your case and proposes a treatment plan. Discovery China arranges a remote consultation — often via video — between your NHS oncologist and the Chinese team so that both sides agree on the regimen, dosing, and timing before you travel.

Step 2: Treatment in China

Chemotherapy is delivered at a Grade 3A hospital oncology day ward, with the same safety and monitoring protocols you would expect in the UK — pre-medication, vital sign monitoring, antiemetic support, and post-cycle observation. Cycle intervals (typically every 2, 3, or 4 weeks) are planned around your travel schedule so you can return to the UK between cycles if appropriate.

Step 3: Handover Back to the NHS

After each cycle — or at the end of the planned course — you receive a complete English-language handover package including chemotherapy administration record, cumulative dose summary, toxicity grading (CTCAE), response assessment, and recommendations for ongoing care. Your NHS oncologist uses this to plan follow-up imaging, blood tests, and any further treatment.

Are the Chemotherapy Regimens the Same?

In most cases, yes. Chinese Grade 3A cancer centres use internationally recognised regimens — FOLFOX, FOLFIRI, R-CHOP, ABVD, gemcitabine-cisplatin, carboplatin-paclitaxel, and so on — that are identical or clinically equivalent to those used in NHS hospitals. The drug names, doses, and scheduling are the same.

Drug manufacturing in China is regulated by the NMPA (National Medical Products Administration), which has mutual recognition agreements with the EMA and FDA for many oncology products. For targeted therapies and immunotherapy, the same brand-name drugs from Roche, Merck, AstraZeneca, Bristol-Myers Squibb, and other major manufacturers are typically used — often sourced through the same global supply chains that serve European hospitals.

Access to CAR-T and Advanced Therapies

One of the most compelling reasons UK cancer patients consider China is access to CAR-T cell therapy and other advanced treatments not yet widely available on the NHS.

China has approved more CAR-T products than any other country:

• Yikaida (axicabtagene ciloleucel) — for DLBCL, approved 2021
• Relma-cel (relmacabtagene autoleucel) — for DLBCL, approved 2021
• Carvykti (ciltacabtagene autoleucel) — for multiple myeloma, approved 2022
• Carteyva — for multiple myeloma, approved 2022
• Fucaso (equecabtagene autoleucel) — for multiple myeloma, approved 2023

These therapies cost $80,000–$150,000 all-inclusive in China, compared with $475,000–$600,000 in the United States. UK patients can typically access CAR-T in China for under $120,000 including hospital stay, apheresis, manufacturing, infusion, and 30-day post-infusion monitoring. For details, see our guide on CAR-T therapy in China for UK patients.

Other advanced therapies available in China that are not yet routinely available on the NHS include bispecific antibodies (glofitamab, mosunetuzumab, talquetamab), BCMA-targeted therapies for myeloma, and a wide range of early-phase clinical trials across solid tumour and haematological malignancies.

What About Insurance?

Standard UK private health insurance (Bupa, AXA, Aviva, Vitality) does not typically cover planned treatment abroad. You will need specialist medical travel insurance that covers your specific situation, including:

• Treatment complications — hospitalisation, ICU admission, surgery for complications
• Travel complications — trip cancellation, extended stay, family member travel
• Medical repatriation — emergency return to the UK if needed
• Follow-up care in the UK — cover for any NHS private treatment related to the procedure

Specialist providers including AllClear, Staysure, Freedom, and Battleface offer policies designed for planned medical treatment abroad. Premiums typically run £50–£300 depending on age, treatment type, and destination.

What to Expect: A Typical Cycle in China

A typical chemotherapy cycle in China follows the same structure as UK delivery, but with a few enhancements:

1. Day 1: Pre-cycle blood tests and consultation with your oncologist (results typically within 2 hours)
2. Day 1-2: Chemotherapy infusion in the day ward, usually 2–6 hours depending on regimen
3. Day 2-3: Post-cycle observation, antiemetic support, hydration, then discharge
4. Day 3-14: Recovery in accessible accommodation, with daily check-ins from your medical concierge and 24-hour on-call support
5. Day 14-21: Return to the UK (or stay for next cycle), with all cycle documentation ready for your NHS team

For patients who want a structured recovery environment between cycles, Discovery China can arrange a wellness programme at the hospital-affiliated rehabilitation centre, or a Yangtze River cruise (subject to clinical clearance) that includes supportive TCM, gentle exercise, and psychological recovery support.

What Your NHS Oncologist Will Need From You

Most NHS oncologists are supportive of dual-track arrangements when properly documented. To help your NHS team feel comfortable with the arrangement, prepare the following:

• A treatment plan from the Chinese team, including drugs, doses, schedule, and rationale
• An emergency contact protocol — who to call in China, who to call in the UK, escalation pathway
• Confirmation that the Chinese team will provide English-language clinical notes after each cycle
• A surveillance plan for the UK — when scans and bloods should happen, who orders them

If your NHS oncologist has concerns, Discovery China can arrange a direct call between the two teams. Most concerns are resolved once the Chinese team's credentials, protocols, and reporting standards are visible.

What to Do Next

If you are considering chemotherapy or another cancer treatment in China while keeping your NHS oncologist in the loop, the first step is a free consultation with Discovery China. We will:

1. Review your diagnosis, staging, and treatment history
2. Match you with a Grade 3A oncology team experienced in your specific cancer type
3. Provide a transparent cost estimate for the planned treatment course
4. Coordinate clinical record transfer and remote consultation between your NHS oncologist and the Chinese team
5. Arrange flights, accommodation, and visa support (China offers visa-free entry for UK citizens for stays up to 240 hours)
6. Provide a complete English-language handover package for your NHS team on return